London Stock Exchange Group plc confirms that the European Commission has conditionally approved, under the EU Merger Regulation, its proposed all share acquisition of Refinitiv (the Transaction).

.@LSEGplc confirms that the European Commission has conditionally approved its proposed all-share acquisition of @Refinitivhttps://t.co/0nTNOcBlh9

— London Stock Exchange Group (@LSEGplc) January 13, 2021

The Transaction remains subject to a small number of merger control and financial regulatory authority approvals and is expected to complete shortly in Q1 2021.

Source: LSEG

EURONEXT UPDATES ON THE CONTEMPLATED ACQUISITION OF THE BORSA ITALIANA GROUP

Euronext today acknowledges that the European Commission has conditionally approved, under the EU Merger Regulation, London Stock Exchange Group’s (LSEG) proposed acquisition of Refinitiv.

Today, the @EU_Commission has conditionally approved @LSEGplc's proposed acquisition of @Refinitiv. This approval meets one of the major conditions in the completion of Euronext’s acquisition of @BorsaItalianaIT: https://t.co/py4U9uVY0t pic.twitter.com/FJH3YcGlRv

— Euronext (@euronext) January 13, 2021

This approval further improves the certainty of execution of Euronext’s contemplated acquisition of the Borsa Italiana Group (the “Transaction”) by satisfying one of the major conditions for the completion of the Transaction. The European Commission’s decision follows the approval of the Transaction by LSEG shareholders on 3 November 2020, by the German Federal Cartel Office on 11 November 2020, by Euronext’s shareholders on 20 November 2020, and the foreign direct investment clearance of the Transaction by the Italian Council of Ministers received on 11 December 2020.

The contemplated acquisition of the Borsa Italiana Group by Euronext is still subject to regulatory approvals in several jurisdictions, a declaration of non-objection from Euronext’s College of Regulators, approval of Euronext as a suitable purchaser by the European Commission and LSEG’s acquisition of Refinitiv. Euronext expects to complete the Transaction in the first half of 2021.

Source: Euronext